TorMagnus Pharmaceuticals

Tormagnus Pharmaceuticals is pioneering targeted drug development strategies by combining scientific and computational principles through machine learning. The company focuses on identifying therapeutic targets for neurodegenerative diseases, particularly Parkinson's disease, with the goal of developing better therapies. Their approach leverages genetics, computation, machine learning, target validation, and small molecule development to create scalable solutions for multiple diseases. They aim to accelerate therapeutic development for patients using innovative technologies.